(Q52630865)

English

Dietary conjugated linoleic acid activates PPARγ and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis.

scientific article published on 17 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

Dietary conjugated linoleic acid activates PPARγ and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

author name string

Sara Borniquel

1

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

Cecilia Jädert

2

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

Jon O Lundberg

3

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

language of work or name

0 references

publication date

17 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

Journal of Nutrition

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

142

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

12

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

2135-2140

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

Intestinal barrier dysfunction in inflammatory bowel diseases.

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Mucins and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Importance and regulation of the colonic mucus barrier in a mouse model of colitis

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Trefoil factors: initiators of mucosal healing

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Colonic anti-inflammatory mechanisms of conjugated linoleic acid

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Peroxisome proliferator-activated receptors: finding the orphan a home

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD.

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Peroxisome proliferator-activated receptor gamma (PPARgamma) regulates trefoil factor family 2 (TFF2) expression in gastric epithelial cells

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

The current future understanding of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Physiological properties of conjugated linoleic acid and implications for human health

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Conjugated linoleic acid and inflammatory cell signalling

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids.

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

The PPAR activator docosahexaenoic acid prevents acetaminophen hepatotoxicity in male CD-1 mice.

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Fatty acids and immune responses--a new perspective in searching for clues to mechanism

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

PPARgamma as a new therapeutic target in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

PPARgamma mediates NSAIDs-induced upregulation of TFF2 expression in gastric epithelial cells

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Aspirin promotes TFF2 gene activation in human gastric cancer cell lines

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Modulation by heme and zinc protoporphyrin of colonic heme oxygenase-1 and experimental inflammatory bowel disease in the rat

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.163931

21 January 2018

Identifiers

10.3945/JN.112.163931

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/23077197

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52630865&oldid=2113850865"